SPL 9.20% 9.5¢ starpharma holdings limited

Ann: DEP docetaxel positive phase 1 results, phase 2 commences, page-41

  1. 255 Posts.
    lightbulb Created with Sketch. 52
    My dad and my aunty passed away. Pancreatic cancer was the cause of it. Very high chance that I have a high risk despite living a healthy lifestyle. So even when things were bad, I thought that putting money into SPL is better than donating to a cancer research charity. (I am sorry if you think this is wrong.) The Oct/Nov 2014 capital raising was cleared as to why the money was being raised. Some cancer research charities I still do donate to but sometimes I wonder if there is a middle man involved.

    I am still unfortunately the smallest shareholder here. I somehow put money into MYX instead of SPL two months ago. Hindsight tells me that I should have top up with more SPL instead. Antibottler was right when he said "now is the time." At this point of time, I have no money to invest, so all I can do is just sit and try to save despite of how hard it might seem.

    When SPL went below $.60, I think a brought the minimum parcel at the around $0.58??? My initial purchase was at $0.695. Also took part in one capital raising. Now an average of $0.645. Not quite 100% gain but SPL is now my second best performing stock.

    My investment in SPL is purely emotional. Wrongly it is. Putting money into SPL is not an investment but a successful SPL could help my health/life later in my life. That's why I never sold during the bad times. Now I must review my decision in MYX. Making the similar "loss" as I did with SPL during SPL's bad times.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.